Trial intelligence / Profile preview

Azilsartan Medoxomil in Pediatric Hypertension

NCT02235909Phase 3Completed

Start
Mar 2015
Primary completion
Nov 2019
Modality
Small Molecules
Countries
12
01

Overview

A Phase 3 trial of azilsartan medoxomil in hypertension (HTN). Started Mar 2015; status: completed.

02

Drugs

azilsartan medoxomil
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on NCT02235909.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02235909.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call